UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000037307 |
|---|---|
| Receipt number | R000042536 |
| Scientific Title | Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab |
| Date of disclosure of the study information | 2019/08/01 |
| Last modified on | 2022/12/28 16:11:40 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2019/07/08 18:13:34 | ||
| 2 | Update | 2019/10/23 11:28:57 | Recruitment status Date of IRB Anticipated trial start date |
|
| 3 | Update | 2020/07/08 09:37:42 | Institutions |
|
| 4 | Update | 2020/07/27 13:06:20 | Basic objectives -Others Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 5 | Update | 2020/07/27 13:20:44 | Narrative objectives1 Basic objectives -Others |
|
| 6 | Update | 2020/07/27 13:29:07 | Key inclusion criteria Key exclusion criteria |
|
| 7 | Update | 2020/07/27 13:53:04 | Institute Institutions |
|
| 8 | Update | 2021/07/09 17:02:48 | Recruitment status Last follow-up date |
|
| 9 | Update | 2021/07/09 17:04:24 | Number of participants that the trial has enrolled |
|
| 10 | Update | 2022/01/11 08:16:18 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 11 | Update | 2022/07/06 15:23:34 | Recruitment status |
|
| 12 | Update | 2022/12/28 16:11:40 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
